MedTrace Logo

Growth and Plasma Amino Acids in Infants With CMPA and Treated With a Newly Innovated Amino Acid Formula

NCT01637688 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2023-03-24

No results posted yet for this study

Summary

The purpose of this study is to determine growth and protein status of infants with cow's milk protein allergy and treated with a newly innovated amino acid formula compared to those with a commercial amino acid formula.

Conditions

  • Cow Milk Allergy

Interventions

DIETARY_SUPPLEMENT

Comparison of treatment with different amino acid formulas

Growth and amino acid status of a newly innovated amino acid formula (NAAF) and a commercial amino acid formula (AAF)

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Narumon Densupsoontorn, MD · Asso.Prof. Narumon Densupsoontorn

Eligibility

Min Age
1 Week
Max Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-01
Primary Completion
2023-06-30
Completion
2023-07-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01637688 on ClinicalTrials.gov